Overview
Hematologic oncologist with an interest in cellular therapies and digital health.
Fellowship: Duke Cancer Institute
Residency: Northwestern University
Medical School: University of Chicago Pritzker School of Medicine
Undergraduate: Yale University
Fellowship: Duke Cancer Institute
Residency: Northwestern University
Medical School: University of Chicago Pritzker School of Medicine
Undergraduate: Yale University
Current Appointments & Affiliations
Assistant Professor of Medicine
·
2023 - Present
Medicine, Hematologic Malignancies and Cellular Therapy,
Medicine
Member of the Duke Cancer Institute
·
2023 - Present
Duke Cancer Institute,
Institutes and Centers
In the News
View All News
Recent Publications
Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium.
Journal Article Blood Cancer J · May 9, 2025 Teclistamab, a BCMA-directed bispecific antibody, received regulatory approval for relapsed/refractory multiple myeloma (RRMM) based on the MajesTEC-1 study. Despite the fact that myeloma is primarily a cancer of elderly adults, only 15% of MajesTEC-1 part ... Full text Link to item CiteFood insecurity prior to hematopoietic stem cell transplant is associated with malnutrition and worse outcomes.
Journal Article Bone Marrow Transplant · April 12, 2025 Food insecurity (FI), defined as the lack of continuous access to adequate food, affects 17-55% of cancer patients. Effects may be exacerbated in hematopoietic stem cell transplant (HSCT) patients, who face nutritional challenges due to treatment side effe ... Full text Link to item CiteOutcomes of Myeloablative Allogeneic Hematopoietic Cell Transplantation with Omidubicel vs Haploidentical and Unrelated Donor Sources
Journal Article Blood Neoplasia · April 2025 Full text CiteRecent Grants
Phase I Trial of Ruxolitinib Plus Fostamatinib for the Treatment of Steroid Refractory Chronic Graft versus Host Disease
Clinical TrialPrincipal Investigator · Awarded by Rigel Pharmaceuticals, Inc. · 2024 - 2029Phase I Trial of Ruxolitinib Plus Fostamatinib for the Treatment of Steroid Refractory Chronic Graft versus Host Disease
Clinical TrialPrincipal Investigator · Awarded by Incyte Corporation · 2024 - 2029Digital Multi-Vital Sign Monitoring for Early Detection of Cytokine Release Syndrome from Bispecific T-Cell Engagers and Chimeric Antigen Receptor Therapy
Clinical TrialPrincipal Investigator · Awarded by Blue Spark Technologies, Inc. · 2024 - 2029View All Grants
Education, Training & Certifications
The University of Chicago ·
2016
M.D.